SELLAS Life Sciences Group, Inc.
SLS • NASDAQ
SELLAS Life Sciences Group, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Angelos Stergiou, with a market cap of $783.9M.
Market Cap$783.9M
Employees17.0
CEOAngelos Stergiou
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
SELLAS Life Sciences Group, Inc. FAQ
Common questions about SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026.
SELLAS Life Sciences Group, Inc. has approximately 17 employees.